The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prescription Pain Medications Market Research Report 2025
Synopsis
Prescription pain relievers are drugs prescribed by a medical professional to reduce pain.
The global Prescription Pain Medications market was valued at US$ 19990 million in 2023 and is anticipated to reach US$ 28000 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prescription Pain Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Pain Medications.
Report Scope
The Prescription Pain Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prescription Pain Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Pain Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Teva
Johnson & Johnson
Allergan
Segment by Type
Prescription NSAIDs
Opioids
Anti-epileptic Medicines
Antidepressants
Others
Segment by Application
Hospitals
Clinics
Drugstores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription Pain Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription Pain Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Prescription pain relievers are drugs prescribed by a medical professional to reduce pain.
The global Prescription Pain Medications market was valued at US$ 19990 million in 2023 and is anticipated to reach US$ 28000 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prescription Pain Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Pain Medications.
Report Scope
The Prescription Pain Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prescription Pain Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Pain Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Teva
Johnson & Johnson
Allergan
Segment by Type
Prescription NSAIDs
Opioids
Anti-epileptic Medicines
Antidepressants
Others
Segment by Application
Hospitals
Clinics
Drugstores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription Pain Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription Pain Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prescription Pain Medications Market Overview
1.1 Product Overview and Scope of Prescription Pain Medications
1.2 Prescription Pain Medications Segment by Type
1.2.1 Global Prescription Pain Medications Market Value Comparison by Type (2024-2030)
1.2.2 Prescription NSAIDs
1.2.3 Opioids
1.2.4 Anti-epileptic Medicines
1.2.5 Antidepressants
1.2.6 Others
1.3 Prescription Pain Medications Segment by Application
1.3.1 Global Prescription Pain Medications Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.3.5 Others
1.4 Global Prescription Pain Medications Market Size Estimates and Forecasts
1.4.1 Global Prescription Pain Medications Revenue 2019-2030
1.4.2 Global Prescription Pain Medications Sales 2019-2030
1.4.3 Global Prescription Pain Medications Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prescription Pain Medications Market Competition by Manufacturers
2.1 Global Prescription Pain Medications Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prescription Pain Medications Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prescription Pain Medications Average Price by Manufacturers (2019-2024)
2.4 Global Prescription Pain Medications Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prescription Pain Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription Pain Medications, Product Type & Application
2.7 Prescription Pain Medications Market Competitive Situation and Trends
2.7.1 Prescription Pain Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prescription Pain Medications Players Market Share by Revenue
2.7.3 Global Prescription Pain Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prescription Pain Medications Retrospective Market Scenario by Region
3.1 Global Prescription Pain Medications Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prescription Pain Medications Global Prescription Pain Medications Sales by Region: 2019-2030
3.2.1 Global Prescription Pain Medications Sales by Region: 2019-2024
3.2.2 Global Prescription Pain Medications Sales by Region: 2025-2030
3.3 Global Prescription Pain Medications Global Prescription Pain Medications Revenue by Region: 2019-2030
3.3.1 Global Prescription Pain Medications Revenue by Region: 2019-2024
3.3.2 Global Prescription Pain Medications Revenue by Region: 2025-2030
3.4 North America Prescription Pain Medications Market Facts & Figures by Country
3.4.1 North America Prescription Pain Medications Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prescription Pain Medications Sales by Country (2019-2030)
3.4.3 North America Prescription Pain Medications Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prescription Pain Medications Market Facts & Figures by Country
3.5.1 Europe Prescription Pain Medications Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prescription Pain Medications Sales by Country (2019-2030)
3.5.3 Europe Prescription Pain Medications Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription Pain Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Prescription Pain Medications Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prescription Pain Medications Sales by Country (2019-2030)
3.6.3 Asia Pacific Prescription Pain Medications Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prescription Pain Medications Market Facts & Figures by Country
3.7.1 Latin America Prescription Pain Medications Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prescription Pain Medications Sales by Country (2019-2030)
3.7.3 Latin America Prescription Pain Medications Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prescription Pain Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription Pain Medications Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prescription Pain Medications Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prescription Pain Medications Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prescription Pain Medications Sales by Type (2019-2030)
4.1.1 Global Prescription Pain Medications Sales by Type (2019-2024)
4.1.2 Global Prescription Pain Medications Sales by Type (2025-2030)
4.1.3 Global Prescription Pain Medications Sales Market Share by Type (2019-2030)
4.2 Global Prescription Pain Medications Revenue by Type (2019-2030)
4.2.1 Global Prescription Pain Medications Revenue by Type (2019-2024)
4.2.2 Global Prescription Pain Medications Revenue by Type (2025-2030)
4.2.3 Global Prescription Pain Medications Revenue Market Share by Type (2019-2030)
4.3 Global Prescription Pain Medications Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prescription Pain Medications Sales by Application (2019-2030)
5.1.1 Global Prescription Pain Medications Sales by Application (2019-2024)
5.1.2 Global Prescription Pain Medications Sales by Application (2025-2030)
5.1.3 Global Prescription Pain Medications Sales Market Share by Application (2019-2030)
5.2 Global Prescription Pain Medications Revenue by Application (2019-2030)
5.2.1 Global Prescription Pain Medications Revenue by Application (2019-2024)
5.2.2 Global Prescription Pain Medications Revenue by Application (2025-2030)
5.2.3 Global Prescription Pain Medications Revenue Market Share by Application (2019-2030)
5.3 Global Prescription Pain Medications Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Prescription Pain Medications Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Prescription Pain Medications Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Grunenthal
6.3.1 Grunenthal Corporation Information
6.3.2 Grunenthal Description and Business Overview
6.3.3 Grunenthal Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grunenthal Prescription Pain Medications Product Portfolio
6.3.5 Grunenthal Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Prescription Pain Medications Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Prescription Pain Medications Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eli Lilly Prescription Pain Medications Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Prescription Pain Medications Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Endo
6.8.1 Endo Corporation Information
6.8.2 Endo Description and Business Overview
6.8.3 Endo Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Endo Prescription Pain Medications Product Portfolio
6.8.5 Endo Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck Prescription Pain Medications Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Depomed
6.10.1 Depomed Corporation Information
6.10.2 Depomed Description and Business Overview
6.10.3 Depomed Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Depomed Prescription Pain Medications Product Portfolio
6.10.5 Depomed Recent Developments/Updates
6.11 Teva
6.11.1 Teva Corporation Information
6.11.2 Teva Prescription Pain Medications Description and Business Overview
6.11.3 Teva Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Teva Prescription Pain Medications Product Portfolio
6.11.5 Teva Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Corporation Information
6.12.2 Johnson & Johnson Prescription Pain Medications Description and Business Overview
6.12.3 Johnson & Johnson Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Johnson & Johnson Prescription Pain Medications Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Allergan
6.13.1 Allergan Corporation Information
6.13.2 Allergan Prescription Pain Medications Description and Business Overview
6.13.3 Allergan Prescription Pain Medications Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Allergan Prescription Pain Medications Product Portfolio
6.13.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prescription Pain Medications Industry Chain Analysis
7.2 Prescription Pain Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription Pain Medications Production Mode & Process
7.4 Prescription Pain Medications Sales and Marketing
7.4.1 Prescription Pain Medications Sales Channels
7.4.2 Prescription Pain Medications Distributors
7.5 Prescription Pain Medications Customers
8 Prescription Pain Medications Market Dynamics
8.1 Prescription Pain Medications Industry Trends
8.2 Prescription Pain Medications Market Drivers
8.3 Prescription Pain Medications Market Challenges
8.4 Prescription Pain Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Prescription Pain Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Prescription Pain Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Prescription Pain Medications Market Competitive Situation by Manufacturers in 2023
Table 4. Global Prescription Pain Medications Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Prescription Pain Medications Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Prescription Pain Medications Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Prescription Pain Medications Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Prescription Pain Medications Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Prescription Pain Medications, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prescription Pain Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prescription Pain Medications, Product Type & Application
Table 12. Global Key Manufacturers of Prescription Pain Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prescription Pain Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Medications as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prescription Pain Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Prescription Pain Medications Sales by Region (2019-2024) & (K Units)
Table 18. Global Prescription Pain Medications Sales Market Share by Region (2019-2024)
Table 19. Global Prescription Pain Medications Sales by Region (2025-2030) & (K Units)
Table 20. Global Prescription Pain Medications Sales Market Share by Region (2025-2030)
Table 21. Global Prescription Pain Medications Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Prescription Pain Medications Revenue Market Share by Region (2019-2024)
Table 23. Global Prescription Pain Medications Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Prescription Pain Medications Revenue Market Share by Region (2025-2030)
Table 25. North America Prescription Pain Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Prescription Pain Medications Sales by Country (2019-2024) & (K Units)
Table 27. North America Prescription Pain Medications Sales by Country (2025-2030) & (K Units)
Table 28. North America Prescription Pain Medications Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Prescription Pain Medications Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Prescription Pain Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Prescription Pain Medications Sales by Country (2019-2024) & (K Units)
Table 32. Europe Prescription Pain Medications Sales by Country (2025-2030) & (K Units)
Table 33. Europe Prescription Pain Medications Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Prescription Pain Medications Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Prescription Pain Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Prescription Pain Medications Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Prescription Pain Medications Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Prescription Pain Medications Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Prescription Pain Medications Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Prescription Pain Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Prescription Pain Medications Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Prescription Pain Medications Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Prescription Pain Medications Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prescription Pain Medications Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Prescription Pain Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Prescription Pain Medications Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Prescription Pain Medications Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Prescription Pain Medications Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Prescription Pain Medications Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Prescription Pain Medications Sales (K Units) by Type (2019-2024)
Table 51. Global Prescription Pain Medications Sales (K Units) by Type (2025-2030)
Table 52. Global Prescription Pain Medications Sales Market Share by Type (2019-2024)
Table 53. Global Prescription Pain Medications Sales Market Share by Type (2025-2030)
Table 54. Global Prescription Pain Medications Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Prescription Pain Medications Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Prescription Pain Medications Revenue Market Share by Type (2019-2024)
Table 57. Global Prescription Pain Medications Revenue Market Share by Type (2025-2030)
Table 58. Global Prescription Pain Medications Price (US$/Unit) by Type (2019-2024)
Table 59. Global Prescription Pain Medications Price (US$/Unit) by Type (2025-2030)
Table 60. Global Prescription Pain Medications Sales (K Units) by Application (2019-2024)
Table 61. Global Prescription Pain Medications Sales (K Units) by Application (2025-2030)
Table 62. Global Prescription Pain Medications Sales Market Share by Application (2019-2024)
Table 63. Global Prescription Pain Medications Sales Market Share by Application (2025-2030)
Table 64. Global Prescription Pain Medications Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Prescription Pain Medications Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Prescription Pain Medications Revenue Market Share by Application (2019-2024)
Table 67. Global Prescription Pain Medications Revenue Market Share by Application (2025-2030)
Table 68. Global Prescription Pain Medications Price (US$/Unit) by Application (2019-2024)
Table 69. Global Prescription Pain Medications Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Prescription Pain Medications Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. GSK Prescription Pain Medications Product
Table 79. GSK Recent Developments/Updates
Table 80. Grunenthal Corporation Information
Table 81. Grunenthal Description and Business Overview
Table 82. Grunenthal Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Grunenthal Prescription Pain Medications Product
Table 84. Grunenthal Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bayer Prescription Pain Medications Product
Table 89. Bayer Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Prescription Pain Medications Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Eli Lilly Corporation Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Eli Lilly Prescription Pain Medications Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. AstraZeneca Prescription Pain Medications Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Endo Corporation Information
Table 106. Endo Description and Business Overview
Table 107. Endo Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Endo Prescription Pain Medications Product
Table 109. Endo Recent Developments/Updates
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Merck Prescription Pain Medications Product
Table 114. Merck Recent Developments/Updates
Table 115. Depomed Corporation Information
Table 116. Depomed Description and Business Overview
Table 117. Depomed Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Depomed Prescription Pain Medications Product
Table 119. Depomed Recent Developments/Updates
Table 120. Teva Corporation Information
Table 121. Teva Description and Business Overview
Table 122. Teva Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Teva Prescription Pain Medications Product
Table 124. Teva Recent Developments/Updates
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Johnson & Johnson Prescription Pain Medications Product
Table 129. Johnson & Johnson Recent Developments/Updates
Table 130. Allergan Corporation Information
Table 131. Allergan Description and Business Overview
Table 132. Allergan Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Allergan Prescription Pain Medications Product
Table 134. Allergan Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Prescription Pain Medications Distributors List
Table 138. Prescription Pain Medications Customers List
Table 139. Prescription Pain Medications Market Trends
Table 140. Prescription Pain Medications Market Drivers
Table 141. Prescription Pain Medications Market Challenges
Table 142. Prescription Pain Medications Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prescription Pain Medications
Figure 2. Global Prescription Pain Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Prescription Pain Medications Market Share by Type in 2023 & 2030
Figure 4. Prescription NSAIDs Product Picture
Figure 5. Opioids Product Picture
Figure 6. Anti-epileptic Medicines Product Picture
Figure 7. Antidepressants Product Picture
Figure 8. Others Product Picture
Figure 9. Global Prescription Pain Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Prescription Pain Medications Market Share by Application in 2023 & 2030
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Drugstores
Figure 14. Others
Figure 15. Global Prescription Pain Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Prescription Pain Medications Market Size (2019-2030) & (US$ Million)
Figure 17. Global Prescription Pain Medications Sales (2019-2030) & (K Units)
Figure 18. Global Prescription Pain Medications Average Price (US$/Unit) & (2019-2030)
Figure 19. Prescription Pain Medications Report Years Considered
Figure 20. Prescription Pain Medications Sales Share by Manufacturers in 2023
Figure 21. Global Prescription Pain Medications Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Prescription Pain Medications Players: Market Share by Revenue in 2023
Figure 23. Prescription Pain Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Prescription Pain Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Prescription Pain Medications Sales Market Share by Country (2019-2030)
Figure 26. North America Prescription Pain Medications Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Prescription Pain Medications Sales Market Share by Country (2019-2030)
Figure 30. Europe Prescription Pain Medications Revenue Market Share by Country (2019-2030)
Figure 31. Germany Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Prescription Pain Medications Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Prescription Pain Medications Revenue Market Share by Region (2019-2030)
Figure 38. China Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Prescription Pain Medications Sales Market Share by Country (2019-2030)
Figure 49. Latin America Prescription Pain Medications Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Prescription Pain Medications Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. U.A.E Prescription Pain Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Prescription Pain Medications by Type (2019-2030)
Figure 59. Global Revenue Market Share of Prescription Pain Medications by Type (2019-2030)
Figure 60. Global Prescription Pain Medications Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Prescription Pain Medications by Application (2019-2030)
Figure 62. Global Revenue Market Share of Prescription Pain Medications by Application (2019-2030)
Figure 63. Global Prescription Pain Medications Price (US$/Unit) by Application (2019-2030)
Figure 64. Prescription Pain Medications Value Chain
Figure 65. Prescription Pain Medications Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
